Content area

|
|

Behandling af tymom og thymuskarcinom

Forfatter(e)
Peter Meidahl Petersen1, Anna Kalhauge2, Bodil Brandt3, Eric Santoni-Rugiu4, Gedske Daugaard1, Jesper Ravn3 & René Horsleben Pedersen3 1) Onkologisk Klinik, Rigshospitalet2) Røntgenafdelingen, Rigshospitalet3) Thoraxkirurgisk Afdeling, Rigshospitalet4) Patologiafdelingen, Rigshospitalet

Ugeskr Læger 2020;182:V08190462
Reference: 
Ugeskr Læger 2020;182:V08190462
Sidetal: 

Peter Meidahl Petersen, Anna Kalhauge, Bodil Brandt, Eric Santoni-Rugiu, Gedske Daugaard, Jesper Ravn & Rene Hornsleben Pedersen:

Management of thymomas and thymic carcinomas

Ugeskr Læger 2020;182:V08190462

This review summarises the diagnostics, staging and treatment of thymic epithelial tumours, of which CT is the current primary imaging. The International Association for the Study of Lung Cancer/International Thymic Malignancy Interest Group TNM staging and the WHO histological classifications are described. Surgery done as total thymectomy with video-assisted thoracoscopic surgery in stage I and open sternotomy in larger stages is the primary treatment if possible. Presurgical tumour reduction with chemotherapy and the possibility of adjuvant radiotherapy after R+ resection is described. Radiotherapy or chemotherapy can be considered, if definite surgery is not possible. Relapse is treated after the same principles as primary disease.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frederik Winsløw | 22/01
2 kommentarer
af Helle Borgstrøm | 22/01
10 kommentarer
af Martin Lindhardt Nielsen | 22/01
1 Kommentar
af Kurt Håkonsson | 19/01
4 kommentarer
af Erik Kristensen | 17/01
20 kommentarer
af Thomas Michael Dan Aru | 17/01
4 kommentarer
af Claus Bo Svenningsen | 15/01
1 Kommentar